Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PlusCBD is a U.S. consumer wellness brand focused on hemp-derived cannabidiol products, including gummies, oils, softgels, balms, and other nutraceutical formulations. The brand operates under CV Sciences and markets research-supported, full-spectrum hemp extract products aimed at everyday wellness rather than prescription therapeutics. PlusCBD emphasizes science-backed formulation, clinical safety work, cGMP-oriented quality systems, CO2 extraction, and broad retail distribution in the United States. The business appears primarily commercial and consumer-facing, with product positioning around sleep, stress, soreness, and general physical and mental wellbeing. Although its parent also references a drug-development effort, PlusCBD itself is best characterized as a branded commercial CBD supplement business rather than a clinical-stage biotech pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PlusCBD.